#92337
#92338
Re: Farmas USA
#92339
Re: Farmas USA
#92340
Re: Farmas USA
#92341
Re: Farmas USA
#92342
Re: Farmas USA
#92343
Re: Farmas USA
#92344
Re: Farmas USA
AMRN
Upgrade de Jefferies
Continue to model success on final analysis. Following Q2 updates, have increased '16 revs$raised our PT to $4.50 (v. $3.50 prev). Anticipates the onset of ~80% of events to occur in H1’17, with interim analysis by the DMC to occur in ~mid-’17